Kollef Marin H, Micek Scott T
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, MO 63110, USA.
Crit Care Med. 2005 Aug;33(8):1845-53. doi: 10.1097/01.ccm.0000171849.04952.79.
To assemble the available clinical data for the prevention of antimicrobial resistance into practical recommendations for clinicians.
A Medline database and references from identified articles were employed to perform a literature search relating to the prevention of antimicrobial resistance.
Antimicrobial resistance has emerged as an important determinant of mortality for patients in the intensive care unit. This is largely due to the increasing presence of pathogenic microorganisms with resistance to existing antimicrobial agents, resulting in the administration of inappropriate treatment. Effective strategies for the prevention of antimicrobial resistance within intensive care units are available and should be aggressively implemented. These strategies can be divided into nonpharmacologic infection control strategies (e.g., routine hand hygiene, implementation of infection-specific prevention protocols) and antibiotic management strategies (e.g., shorter courses of appropriate antibiotic treatment, narrowing of antimicrobial spectrum based on culture results). Increasing current efforts aimed at the prevention of antimicrobial resistance is especially important given the limited availability of new antimicrobial drug classes for the foreseeable future.
整合预防抗菌药物耐药性的现有临床数据,为临床医生提供实用建议。
使用Medline数据库以及已识别文章中的参考文献进行与预防抗菌药物耐药性相关的文献检索。
抗菌药物耐药性已成为重症监护病房患者死亡率的重要决定因素。这主要是由于对现有抗菌药物耐药的致病微生物越来越多,导致治疗不当。重症监护病房内预防抗菌药物耐药性的有效策略是可行的,应积极实施。这些策略可分为非药物感染控制策略(如常规手部卫生、实施特定感染预防方案)和抗生素管理策略(如适当缩短抗生素治疗疗程、根据培养结果缩小抗菌谱)。鉴于在可预见的未来新抗菌药物种类有限,加大目前预防抗菌药物耐药性的力度尤为重要。